Cyteir Therapeutics Inc. (CYT)
NASDAQ: CYT
· Real-Time Price · USD
3.02
-0.07 (-2.27%)
At close: Mar 15, 2024, 9:00 PM
Cyteir Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -3.53M | -8.4M | -12.49M | -8.79M | -11.04M | -12.12M | -14.1M | -11.81M | -11.7M | -11.29M | -7.31M |
Depreciation & Amortization | 110K | 108K | 150K | 170K | 170K | 169K | 159K | 140K | 125K | 111K | 103K |
Stock-Based Compensation | 599K | 776K | 1.04M | 869K | 1.19M | 1.36M | 1.25M | 1.13M | 1.07M | 772K | 488K |
Other Working Capital | -902K | 2.71M | 454K | 1.22M | -1.09M | -652K | -1.35M | 2.47M | -2.31M | 1.94M | 16K |
Other Non-Cash Items | 1.64M | 319K | 765K | 156K | 153K | 244K | 154K | 2.15M | n/a | n/a | n/a |
Deferred Income Tax | -1.64M | -319K | n/a | n/a | n/a | n/a | n/a | -2.15M | n/a | n/a | n/a |
Change in Working Capital | -1.73M | 3.37M | 362K | 681K | -3.04M | -537K | 366K | 925K | -2.42M | 3.3M | 347K |
Operating Cash Flow | -4.56M | -4.15M | -10.17M | -6.92M | -12.57M | -10.88M | -12.17M | -9.62M | -12.93M | -7.11M | -6.37M |
Capital Expenditures | n/a | n/a | n/a | -302K | -10K | -111K | -191K | -503K | -394K | -114K | -178K |
Cash Acquisitions | n/a | 153K | 150K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 153.00 | 150.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | 153K | 150K | -302K | -10K | -111K | -191K | -503K | -394K | -114K | -178K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 164K | 428K | 103K | 147K | 71K | 5K | 19K | 21K | 14.51M | 121.67M | 79.81M |
Financial Cash Flow | 164K | 428K | 103K | 147K | 71K | 5K | 19K | 21.00 | 14.51K | 121.67K | 79.81K |
Net Cash Flow | -4.39M | -3.57M | -9.91M | -6.77M | -12.51M | -10.99M | -12.34M | -10.1M | 1.19M | 114.44M | 73.26M |
Free Cash Flow | -4.56M | -4.15M | -10.17M | -7.22M | -12.58M | -10.99M | -12.36M | -10.12M | -13.32M | -7.22M | -6.55M |